[go: up one dir, main page]

GB0208624D0 - Use of aplidine for the treatment of pancreatic cancer - Google Patents

Use of aplidine for the treatment of pancreatic cancer

Info

Publication number
GB0208624D0
GB0208624D0 GB0208624A GB0208624A GB0208624D0 GB 0208624 D0 GB0208624 D0 GB 0208624D0 GB 0208624 A GB0208624 A GB 0208624A GB 0208624 A GB0208624 A GB 0208624A GB 0208624 D0 GB0208624 D0 GB 0208624D0
Authority
GB
United Kingdom
Prior art keywords
aplidine
treatment
pancreatic cancer
pancreatic
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0208624A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Priority to GB0208624A priority Critical patent/GB0208624D0/en
Publication of GB0208624D0 publication Critical patent/GB0208624D0/en
Priority to AT02770106T priority patent/ATE411036T1/en
Priority to EP02770106A priority patent/EP1435991B1/en
Priority to PCT/GB2002/004816 priority patent/WO2003033013A1/en
Priority to AU2002336206A priority patent/AU2002336206B2/en
Priority to CA002462642A priority patent/CA2462642A1/en
Priority to US10/492,659 priority patent/US20050004012A1/en
Priority to DE60229414T priority patent/DE60229414D1/en
Priority to PT02770106T priority patent/PT1435991E/en
Priority to ES02770106T priority patent/ES2315404T3/en
Priority to US12/604,900 priority patent/US20100041594A1/en
Ceased legal-status Critical Current

Links

GB0208624A 2001-10-19 2002-04-15 Use of aplidine for the treatment of pancreatic cancer Ceased GB0208624D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB0208624A GB0208624D0 (en) 2002-04-15 2002-04-15 Use of aplidine for the treatment of pancreatic cancer
ES02770106T ES2315404T3 (en) 2001-10-19 2002-10-21 USE OF APLIDINE FOR THE TREATMENT OF PANCREAS CANCER.
AU2002336206A AU2002336206B2 (en) 2001-10-19 2002-10-21 Use of aplidine for the treatment of pancreatic cancer
EP02770106A EP1435991B1 (en) 2001-10-19 2002-10-21 Use of aplidine for the treatment of pancreatic cancer
PCT/GB2002/004816 WO2003033013A1 (en) 2001-10-19 2002-10-21 Use of aplidine for the treatment of pancreatic cancer
AT02770106T ATE411036T1 (en) 2001-10-19 2002-10-21 USE OF APLIDINE IN THE TREATMENT OF PANCREAS CANCER
CA002462642A CA2462642A1 (en) 2001-10-19 2002-10-21 Use of aplidine for the treatment of pancreatic cancer
US10/492,659 US20050004012A1 (en) 2001-10-19 2002-10-21 Use of aplidine for the treatment of pancreatic cancer
DE60229414T DE60229414D1 (en) 2001-10-19 2002-10-21 USE OF APLIDINE IN THE TREATMENT OF PANCREATIC CANCER
PT02770106T PT1435991E (en) 2001-10-19 2002-10-21 Use of aplidine for the treatment of pancreatic cancer
US12/604,900 US20100041594A1 (en) 2001-10-19 2009-10-23 Use of Aplidine for the Treatment of Pancreatic Cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0208624A GB0208624D0 (en) 2002-04-15 2002-04-15 Use of aplidine for the treatment of pancreatic cancer

Publications (1)

Publication Number Publication Date
GB0208624D0 true GB0208624D0 (en) 2002-05-22

Family

ID=9934867

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0208624A Ceased GB0208624D0 (en) 2001-10-19 2002-04-15 Use of aplidine for the treatment of pancreatic cancer

Country Status (1)

Country Link
GB (1) GB0208624D0 (en)

Similar Documents

Publication Publication Date Title
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
IL164599A0 (en) Combination therapy for the treatment of cancer
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
IL164896A0 (en) Immunoconjugates for the treatment of tumours
ZA200500618B (en) Combinations of drugs for the treatment of neoplasms
AU2003212634A8 (en) Compounds useful in the treatment of cancer
GB0223367D0 (en) Therapeutic treatment
AU2003251904A8 (en) Combinations of drugs for the treatment of neoplasms
GB0213869D0 (en) The treatment of pain
AU2003251875A8 (en) Combination therapy for the treatment of neoplasms
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GB0223854D0 (en) Therapeutic treatment
AU2003223538A1 (en) Methods for the treatment of cancer
LT1496918T (en) Use of sodium meta-arsenite for the treatment of tumours
AU2003296545A8 (en) Use of a trpm8-activating substance for the treatment of tumours
GB0210464D0 (en) Therapeutic treatment
AU2003231803A8 (en) Treatment of cancer with mefloquire
EP1684795A4 (en) Methods and agents for the treatment of cancer
GB0329416D0 (en) Treatment of cancer
PT1680405E (en) Bengamide derivatives and use thereof for the treatment of cancer
GB0201025D0 (en) The treatment of degenerative diseases
GB0208624D0 (en) Use of aplidine for the treatment of pancreatic cancer
GB2415379B (en) Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)